I now have everything needed for a comprehensive, well-illustrated answer. Here is the full response:
Fluid Replacement in Dengue
Dengue fluid management is driven by disease severity. The plasma leakage phase (days 3-7 of illness) is the most dangerous window, and fluid therapy must be calibrated to the grade of disease. Haematocrit and vital signs are the primary guides throughout.
WHO Grading - Quick Reference
| Grade | Classification | Key Feature |
|---|
| DF | Dengue Fever | No plasma leakage; Hct rise 5-10% |
| DHF I | Mild DHF | Hct rise ≥20%, platelet <100,000; positive tourniquet test |
| DHF II | Moderate DHF | Above + spontaneous bleeding |
| DHF III | Compensated Shock | Pulse pressure ≤20 mmHg, weak rapid pulse, cold clammy extremities |
| DHF IV | Profound Shock | Undetectable BP/pulse (Dengue Shock Syndrome) |
1. Dengue Fever (DF) - Outpatient Oral Therapy
Patients tolerating oral fluids with urine output at least once every 6 hours and no warning signs can be managed at home:
- Oral rehydration solution (ORS), fruit juices, and electrolyte-containing fluids - preferred over plain water, as plain water does not replace electrolytes lost from fever and vomiting
- Caution: Glucose-containing fluids may exacerbate hyperglycaemia in diabetics and during physiological stress
- Paracetamol for fever; dose interval not less than 6 hours. Tepid sponging for persistent high fever
- Avoid aspirin, ibuprofen, and all NSAIDs - they aggravate gastritis, bleeding, and aspirin may precipitate Reye's syndrome
- IV fluids indicated only if persistent vomiting or refusal to feed
Return immediately if: no improvement, abdominal pain, persistent vomiting, black tarry stools, cold extremities, lethargy, or no urine for >4-6 hours.
2. DHF Grades I & II - IV Fluid Algorithm
Haemoconcentration (Hct rise ≥20%) with thrombocytopenia is the trigger for IV therapy.
Starting point: IV crystalloid at 6 ml/kg/h for 1-2 hours, then check Hct.
If improvement (Hct falls, pulse and BP stable, urine output rises):
- Reduce IV crystalloid stepwise: 6 ml/kg/h → 3 ml/kg/h (2-4 h) → 1.5 ml/kg/h (2-4 h)
- Discontinue IV after 24-48 hours
If no improvement - Hct rises:
- Increase to 10 ml/kg/h crystalloid for 2 hours, reassess
If no improvement - Hct falls (suspect internal haemorrhage):
- Blood transfusion: 10 ml/kg whole blood or 5 ml/kg packed RBCs
- After improvement: step down to 10 → 6 → 3 ml/kg/h, discontinue after 24-48 h
3. DHF Grade III (Compensated Shock) - IV Fluid Algorithm
Trigger: Pulse pressure ≤20 mmHg, SBP <90 mmHg, Hct rise >20% from baseline.
Starting point: IV crystalloid at 10-20 ml/kg/h for 1 hour, then assess vital signs (VS) and Hct.
If improvement in VS and Hct:
- Step down: 10 ml/kg/h → 6 ml/kg/h (2-4 h) → 1.5 ml/kg/h (2-4 h)
- Discontinue IV after 24-48 hours
If no improvement - Hct rises or stays >45%:
- Give IV colloid OR crystalloid 10-20 ml/kg over 1 hour
- Colloids used: Dextran 40 or degraded gelatine polymer (polygeline)
If no improvement - Hct falls (suspect bleeding):
- Blood transfusion: 10 ml/kg whole blood or 5 ml/kg packed RBCs
- If still refractory hypotension → check ABCS (Acidosis, Bleeding, Calcium/electrolytes, Sugar)
- If VS still not improving → IV inotropes with crystalloid maintenance by Holliday-Segar formula
4. DHF Grade IV (Profound Shock / DSS)
- Same algorithm as Grade III but shock is more profound (undetectable BP/pulse)
- Oxygen to all patients in shock - mandatory
- IV crystalloid resuscitation initiated immediately on hospitalization
- If already received ~1000 ml IV fluid and no improvement: switch to colloidal solution (Dextran 40/haemaccel) or, if Hct is declining, fresh whole blood 10-20 ml/kg/h
- For persistent shock with declining Hct despite colloid - suspect internal bleeding; give fresh whole blood 10 ml/kg/h routinely as a precaution
5. Indications for Red Cell Transfusion
- Overt blood loss ≥10% of total blood volume - give whole blood or components
- Refractory shock despite adequate IV fluids with declining Hct
- Replacement volume: 10 ml/kg body weight at a time; obtain coagulogram first
- If fluid overload is present: use packed cells instead of whole blood
6. Types of IV Fluid - What to Use
| Type | Examples | When to Use |
|---|
| Crystalloid | Normal saline (0.9% NaCl), Ringer's lactate | First-line for all grades |
| Colloid | Dextran 40, polygeline (degraded gelatine) | When crystalloid fails, Hct rising, shock persists |
| Blood/pRBC | Fresh whole blood, packed RBCs | Declining Hct + shock, overt/suspected internal bleeding |
Note: In cases of acidosis, Ringer's lactate (hyperosmolar solution) should NOT be used.
7. Monitoring Parameters
- Haematocrit: Serial monitoring every hour in shock; daily from day 3 until afebrile for 1-2 days
- Platelet count: Drop in platelets + rise in Hct = early warning for DHF
- Vital signs and urine output: Every hour in DHF grades III/IV
- Improvement defined as: Hct falls, pulse rate and BP stabilise, urine output rises
- No improvement / deterioration: Hct or pulse rate rises, pulse pressure falls below 20 mmHg, urine output falls
8. Key Principles - Summary
- Fluid therapy is entirely supportive - no specific antivirals exist for dengue
- The goal is to bridge the plasma leakage phase (typically 24-48 hours during defervescence) without causing fluid overload
- Over-resuscitation is as dangerous as under-resuscitation - fluid overload causes pulmonary oedema, particularly once plasma reabsorption begins (recovery phase)
- IV fluids should be discontinued within 24-48 hours of clinical improvement
- NSAIDs and aspirin are absolutely contraindicated in all dengue grades
- DSS patients require ICU admission
Sources: Park's Textbook of Preventive and Social Medicine, pp. 293-297; Rosen's Emergency Medicine: Concepts and Clinical Practice, p. 2630; Creasy & Resnik's Maternal-Fetal Medicine, p. 12.
Recent evidence: A 2025 systematic review (PMID: 41037858) on dengue pathogenesis, diagnosis, and management confirms the WHO-based supportive fluid approach remains standard of care with no new antivirals approved.